TechEmerge Health India
In partnership with:
IFC launched its very first TechEmerge initiative in 2016, with an open call for innovators across the globe to bring new technologies to India’s health care sector. After a thorough needs assessment and curated matchmaking, 22 pilots kicked off at 70 clinical sites in urban and rural locations across India to address clinical and operational gaps in the health care ecosystem.
By the end of 2018, TechEmerge Health India pilots had reached over 18,000 patients with innovations in operational efficiency, patient engagement, remote monitoring, patient safety, point-of-care diagnostics, and telemedicine.
Innovators and Indian health care providers signed 22 commercial contracts worth over $1 million as a result of the program. These are expected to benefit more than 300,000 patients annually. Several innovators signed local distributors and went on to work with other health providers for broader deployment of their solutions in India. During the program, our tech companies raised $14.5 million, and one was acquired for over $100 million.
Read our Stories from the Field
India's population in 2021
India's healthcare market expected size by 2022
The Indian diagnostics market value in 2021
India’s unmet demand for health services, its attractive market for tech companies, and strong IFC footprint made it a good candidate for TechEmerge’s inaugural health program.
Like many developing countries, India battles with communicable diseases and a rise in non-communicable conditions like heart disease, diabetes and cancer. These challenges are compounded by a lack of access to basic health care, with just seven doctors per 10,000 people and a shortage of health infrastructure. The private sector provides most health care in India. However, only 17 percent of people are insured, and about 70 percent of health care expenditure is paid out of pocket.
Despite these complex challenges, with 1.3 billion people, the opportunities in India are significant – insurance coverage is expected to expand and business models to meet the country’s diverse needs will also evolve and spur growth. This is, driven by a steady rise in income – the Indian median income per household is expected to increase by 90 percent between 2015 and 2030 – giving people greater capacity to invest in preventative care and diagnostic procedures.
This presented opportunities for health technology innovators to enter the Indian market, and for local health care providers to adopt new solutions that increase operational efficiency and improve patient outcomes.
TechEmerge Health India was supported by a network of advisors from across the globe with decades of experience in health, technology, the Indian market, investment, and working with startups.
Managing Director, Merck Global Health Innovation Fund
Vice President, Healthbox
President, Aditya Birla Management Corporation
Manager, Health Village Capital
Co-founder, Equilateral Ventures
Managing Director, Digital Healthcare - Claremont Creek
Vice President, NYeC
Lead, Division of Medical Informatics, St. John's National Academy of Health Sciences
Executive Director, IMS Institute for Healthcare Informatics
Partner, Aberdare Ventures
Tamara St. Clarie
Chief Innovation Officer, Commercial Healthcare, Xerox
Co-Founder, Startup Health
General Partner, Health and Wellness Lead, Ideo
Chief Executive Officer, eHealth Ventures
Faculty Director, MIT Accelerated Medical Ventures
Associate Director, Innovations at Henry Ford Health System
Principal, Unitus Seed Fund
CTO and VP, Engineering, Castlight Health
Resident Fellow and Leadership Group Member, Ashoka
Independent Consultant, Israeli Office of the Chief Scientist
Independent Consultant, Israeli Office of the Chief Scientist
Chief Advisor, Health and well-being, Tekes
Senior Consultant, NIRAS Finland
Vice President, NASSCOM
Anne Katharine Wales
Sr. Program Manager, Innovations in Healthcare
Barath Shankar Subramanian
Director, Adroa Healthcare
Co-Founder & Director, Arogya Finance
Investment Associate, Aspada
Founder & Executive Director, BIORx Venture Advisors Pvt. Ltd.
Vice President, Healthcare (India) Director, Medical Screening & Software Solutions (Germany)
Associate Vice President, Emerging Markets & Innovation Lab, Intellecap
Senior Manager, 10,000 Startups, Nasscom
Vice President, SNSK Associates
Founder& CEO, InnAccel
Director, Clinical Innovation and Partnerships, InnAccel
VP Architecture, Lumiata
Senior Director Innovation R&D, Cigna
Our 15 technology adopters are leading companies in India’s health ecosystem, including multi-specialty hospitals, speciality clinics, laboratories and diagnostic centers with over 60,000 beds in 400 locations.
Competitively selected from a field of more 330 companies from 29 countries, our 17 innovators piloted a wide range of cost-effective, accessible, effective health technologies and solutions.
In total, the TechEmerge Health India initiative supported 20 successful pilot projects focused on operational efficiency, patient engagement, remote monitoring, patient safety, point-of-care diagnostics, and more.
Micromedic Technologies / SRL Diagnostics
Micromedic Technologies’ CellDetect® is a staining technology used to simplify and expedite screening of women at risk of developing cervical cancer. It is the only histochemical platform allowing color discrimination alongside morphological examination for differentiation between normal and cancerous cells. In this pilot, cervical specimens collected at SRL Diagnostics' pathology laboratory were analyzed using CellDetect® to boost the detection of early-stage and pre-cancer lesions. The primary goal of this pilot was to test the efficacy, utility, and overall usability of CellDetect® in SRL Diagnostics' reference pathology laboratory.
Micromedic Technologies/Dr. Lal Pathlabs
Micromedic Technologies created CellDetect®, a staining technology that combines color and morphology to screen women at risk of developing cervical cancer. In this pilot, CellDetect was used to analyze cervical specimens collected at Dr. Lal PathLabs to simplify & expedite the interpretation of microscopic slides and boost the detection of early stage and pre-cancer lesions.
ChatrHealth / Narayana Health
In partnership with Narayana Health, ChatrHealth piloted standardized checklists and protocols aimed at improving efficiency and safety before, during, and after medical procedures in surgical operating rooms, and preventing surgical errors.
Bodhi Health / NephroPlus
In this pilot, Bodhi Health Education’s learning management system deployed standardized online training modules in dialysis for NephroPlus staff at the company’s corporate training facility in Hyderabad. The pilot aimed to support high demand for dialysis and rapid growth in the company.
Bodhi Health / EyeQ Hospital
Bodhi Health Education’s learning management system deployed standardized training solutions for technicians at EyeQ. In this pilot, online training modules were used to standardize the training process, conduct assessments, track performance of individual learners and gain insights on analytics from each center.
WellDoc / Max Healthcare
WellDoc's BlueStar is a mobile prescription therapy application for adults with Type 2 diabetes. This pilot with Max Healthcare used BlueStar to track blood glucose levels, medications, and dietary habits over time to improve patient engagement and decrease patients' HbA1c levels.
Diabetacare – Medanta
Diabetacare's Clinico-Technology Solution enhances patient care by providing real-time alerts after every blood sugar check, minimizing risk of errors and improving clinical outcomes. Their pilot with Medanta will aim to control hyperglycemia in patients with diabetes.
mTatva / Apollo Hospitals
mTatva developed a text-message enabled ‘digital-nurse’ called HealthPIE. During this pilot, Apollo Hospital providers trialed mTava’s post-prescription technology solution to scan and digitize investigations, medicines, reviews, and other details on a patient’s paper prescription, and provide SMS reminders to increase patient engagement.
Point of Care
Zilico / International Oncology
Zilico created ZedScan, which uses Electrical Impedance Spectroscopy (EIS) to improve the detection of cervical cancer following an abnormal smear result and increase diagnostic accuracy - ultimately saving lives and money. Results are displayed on a handset within a simple graphical interface, whereas conventional colposcopy relies on visual indicators, which are not disease specific, and can result in overtreatment and misdiagnosis. This pilot with International Oncology aimed to increase early detection and quickly enable treatment.
Ceeable / Dr. Agarwal’s Eye Hospital
Ceeable piloted their web-based 3D Visual Field Analyzer (CVFA) system at Dr. Agarwal clinic sites to quickly and accurately screen patients for eye disease, including retina disorders such as glaucoma, macular degeneration, and diabetic retinopathy. In addition to rapid screening, the Ceeable test is intended to increase diagnostic and hospital efficiencies by allowing clinicians to quickly access comprehensive test results upon completion of testing. The pilot compared Ceeable’s test with the standard procedures for macular degeneration patients.
Remote diagnosis using cloud-enabled electrocardiogram platform
The Tricog system is a platform that enables remote diagnosis of heart abnormalities using off-the-shelf, cloud-enabled electrocardiogram machines. In this pilot, the Tricog system transmitted data to the Cygnus hub, where data was reviewed and interpreted by Cygnus’ expert doctors, and a diagnosis was then sent back to clinics at remote locations through SMS, mobile app, and email within five minutes or less.
Transmural Biotech / Cloudnine
Transmural Biotech developed quantusFLM, a non‐invasive, fast, and easy‐to‐use Fetal Lung Maturity test that provides an accurate result within three minutes. The pilot with Cloudnine tested quantusFLM in the clinical practice of three maternity hospitals, with pregnant women at risk of late pre-term birth, or scheduled for an early term birth, to determine Fetal Lung Maturity by using only an ultrasound image during quantusFLM analysis.
Mobile ODT / Apollo Hospitals
Mobile ODT created the Enhanced Visual Assessment (EVA) System, an integrated cervical cancer screening and patient tracking system that enables ongoing engagement with patients through a smartphone platform. In this pilot, Apollo Hospitals integrated the EVA system for digital cervicography into their primary screening for cervical cancer to reduce “loss to follow-up" and to provide point-of-care diagnosis. The primary objective of the pilot was to evaluate the effectiveness of the EVA System, in comparison to existing cervical cancer screening techniques at various Apollo Hospital centers, and to ensure it meets quality standards. A secondary goal was to conduct quality assurance through image review of all screeners by an expert colposcopist in the secure, online portal to better understand the skill level and uniformity of protocol followed by providers.
Mobile ODT / International Oncology
Mobile ODT's Enhanced Visual Assessment (EVA) System is an integrated cervical cancer screening and smartphone-based patient tracking system that enables ongoing patient engagement. International Oncology tested the EVA System in cervical cancer screening programs in affiliated hospitals and outreach centers to minimize "loss to follow-up" care among patients who screen positive on primary cervical cancer screening tests.The primary objective of the pilot was to evaluate the effectiveness of the EVA System, in comparison to existing cervical cancer screening techniques at screening camps supported by International Oncology to ensure the technology met the highest quality screening standards.
Optomed / EYEQ Hospitals
Optomed Oy has created a portable cloud-based retinal camera. In this pilot, retinal surgeons and senior optometrists at EyeQ’s super specialty eye hospitals compared the analysis of angiography images from Optomed Oy’s low-cost, portable Smartscope FFA camera with images from conventional FFA cameras in order to improve access to quality eye healthcare in rural India.
Vios Medical / Regency Healthcare
Vios Medical created the Vios Monitoring System (VMS), allowing automated continuous surveillance of patients’ physiological vital signs in a non-ICU setting. In this pilot, Vios implemented monitoring systems in general medical-surgical wards at Regency Healthcare allowing clinicians to monitor, manage, and provide care to patients remotely.
Stasis Labs / CloudNine
Stasis Labs piloted its Stasis Monitoring System, a bedside monitoring system, along with a portable tablet that serves as a patient chart, in Cloudnine Bangalore Jayanagar branch hospital wards to monitor patients who no longer need intensive care but still need monitoring.
Stasis Labs / Narayana Health
Stasis Labs created the Stasis Monitoring System (SMS). This pilot trialed the bedside monitoring system, along with a portable tablet that serves as a patient chart, in multiple Narayana Health hospital wards in order to de-congest the intensive care unit and improve operational efficiency. The primary objective was to understand whether clinicians and nurses were able to use the product effectively to improve the quality of care for their patients.
Equatel / Max Healthcare
The Equatel Touch device connects rural communities with public healthcare kiosks and services. In this pilot, the Equatel Touch device will be deployed in Max Healthcare rural clinics and outreach programs to provide efficient healthcare services to rural communities, as well as in urban hospital centers, in order to streamline and manage their admittance and pre-screenings.
As a result of participating in TechEmerge, our innovators signed 22 contracts with Indian health care providers within one year of completing their pilots. Several went on to sign contracts with local distributors for broader deployment of their solutions across India.
Successful pilots conducted by 15 innovators and 13 healthcare providers
Commercial contracts signed by innovators & Indian healthcare providers
Value of commercial contacts generated by the program
Patients expected to benefit each year from deployment of these technologies
Raised by innovators during the program
One of our innovators was acquired during the program
"Being selected in TechEmerge was a key turning point...we took what we learned from the TechEmerge pilot project, replicated it in other markets, and have grown over 1 million patients in 12 countries."
Innovator in :
"India was not a market that we expected to enter before 2019... But being selected as one of the companies involved in the program has accelerated the initial plan. Entering such a big and complex country without the program would have been very difficult at this stage. TechEmerge has provided us the training, the initial contacts and the platform to start commercial actions [in India]."
Innovator in : TechEmerge Health India
"The collaboration with Dr. Agarwal's' Hospital has been a deep learning experience and will lead to further collaborative projects in India."
Innovator in : TechEmerge Health India
"The TechEmerge program is powerful in that it funds and brings together unmeet needs with powerful solutions, aimed at bringing innovation to the developing world. The team at TechEmerge is also very professional, world-class."
Welldoc/ Max healthcare
Innovator in : TechEmerge Health India